In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch

172Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

Abstract

β-Galactosidase (β-gal) has been widely used as a transgene reporter enzyme, and several substrates are available for its in vitro detection. The ability to image β-gal expression in living animals would further extend the use of this reporter. Here we show that DDAOG, a conjugate of β-galactoside and 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) (DDAO), is not only a chromogenic β-gal substrate but that the cleavage product has far-red fluorescence properties detectable by imaging. Importantly, the cleavage substrate shows a 50-nm red shift, enabling its specific detection in a background of intact probe, a highly desirable feature for in vivo imaging. Specifically, we show that β-gal-expressing 9L gliomas are readily detectable by red fluorescence imaging in comparison with the native 9L gliomas. We furthermore show that herpes simplex virus amplicon-mediated LacZ gene transfer into tumors can be transiently and thus serially visualized over time. The results indicated that in vivo real-time detection of β-gal activity is possible by fluorescence imaging technology.

Cite

CITATION STYLE

APA

Tung, C. H., Zeng, Q., Shah, K., Kim, D. E., Schellingerhout, D., & Weissleder, R. (2004). In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch. Cancer Research, 64(5), 1579–1583. https://doi.org/10.1158/0008-5472.CAN-03-3226

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free